Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
DEA Transcript Moves Federal Cannabis Rescheduling Toward Recommendation
DEA has released the complete 2,533 page transcript from 11 days of federal cannabis rescheduling hearings as the administrative law judge prepares a recommendation. The record moves the process closer to a decision while operators continue facing uncertainty around 280E, federal compliance, medical cannabis strategy, research, and investment timing.
Cannabis Legalization Could Generate $111 Billion In Federal Tax Revenue
A Yale Budget Lab analysis estimates federal cannabis legalization could produce $57.9 billion in federal excise tax revenue over ten years, rising to $111.3 billion if every remaining state also legalizes. The bigger operator question is how legalization would reshape taxation, 280E, banking, interstate commerce, illicit market competition, and the economics of the regulated industry.
Illinois Adult Use Retailers Gain Medical Cannabis Permit Path
Illinois adult use dispensaries will be able to opt into medical cannabis licensing beginning September 10, opening new opportunities around patient access, retail sales, DEA registration, and federal tax planning. The bigger lesson is that cannabis license structure is becoming increasingly important as state medical programs interact with new federal Schedule III rules.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.